Michael Gould to Early Detection of Cancer
This is a "connection" page, showing publications Michael Gould has written about Early Detection of Cancer.
Connection Strength
5.651
-
Inappropriate Determinations of Inappropriateness for Lung Cancer Screening. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):130-131.
Score: 0.644
-
Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit? JAMA Netw Open. 2022 11 01; 5(11):e2243171.
Score: 0.593
-
Facilitating Adherence to Annual Screening for Lung Cancer: Are Program-Level Interventions Enough? Chest. 2022 07; 162(1):8-10.
Score: 0.579
-
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study. BMJ Open. 2022 06 22; 12(6):e064142.
Score: 0.578
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.421
-
Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017 Aug; 14(8):1261-1265.
Score: 0.412
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.386
-
Lung cancer screening and elderly adults: do we have sufficient evidence? Ann Intern Med. 2014 Nov 04; 161(9):672-3.
Score: 0.341
-
Favorable stage distribution in the NELSON trial: promise or hype? Am J Respir Crit Care Med. 2013 Apr 15; 187(8):792-3.
Score: 0.306
-
When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012 Oct 16; 157(8):571-3.
Score: 0.295
-
Barriers and facilitators to implementation and sustainment of guideline-recommended depression screening for patients with breast cancer in medical oncology: a qualitative study. Support Care Cancer. 2023 Jul 12; 31(8):461.
Score: 0.155
-
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med. 2017 10 01; 196(7):e15-e29.
Score: 0.104
-
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps. Cancer Epidemiol Biomarkers Prev. 2016 11; 25(11):1449-1455.
Score: 0.096
-
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
Score: 0.088
-
Attitudes about low-dose computed tomography screening for lung cancer: a survey of American Thoracic Society Clinicians. Am J Respir Crit Care Med. 2015 Feb 15; 191(4):483-6.
Score: 0.087
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.086
-
Clinical practice. Lung-cancer screening with low-dose computed tomography. N Engl J Med. 2014 Nov 06; 371(19):1813-20.
Score: 0.085
-
Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery. Thorax. 2011 Apr; 66(4):277-9.
Score: 0.066
-
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
Score: 0.037
-
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 11; 175(11):1501-1505.
Score: 0.037
-
Stakeholder Research Priorities to Promote Implementation of Shared Decision-Making for Lung Cancer Screening: An American Thoracic Society and Veterans Affairs Health Services Research and Development Statement. Am J Respir Crit Care Med. 2022 03 15; 205(6):619-630.
Score: 0.035
-
A Patient Portal-Based Commitment Device to Improve Adherence with Screening for Colorectal Cancer: a Retrospective Observational Study. J Gen Intern Med. 2021 04; 36(4):952-960.
Score: 0.033
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.031
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854.
Score: 0.031
-
Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
Score: 0.030
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.025
-
Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial. Chest. 2016 09; 150(3):621-30.
Score: 0.024
-
The Online Personal Action Plan: A Tool to Transform Patient-Enabled Preventive and Chronic Care. Am J Prev Med. 2016 07; 51(1):71-7.
Score: 0.023
-
An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management. Am J Respir Crit Care Med. 2015 Aug 15; 192(4):500-14.
Score: 0.022